ClinicalTrials.Veeva

Menu
S

Stanford Health Care | Stanford Neuroscience Health Center (SNHC)

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

BHV-7000
Platinum
Voriconazole
Isavuconazonium sulfate
Posaconazole
Risdiplam
JNJ-81201887
thiazide

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

6 of 20 total trials

A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events (TRANSFORM)

TRANSFORM is a prospective, randomized, open blinded endpoint (PROBE), event-driven, pragmatic trial in patients who are at increased risk for athero...

Enrolling
Diabetes Mellitus, Type 2
Metabolic Syndrome
Device: The Cleerly CAD Staging System

The purpose of this study is to determine whether BHV-7000 is effective in the treatment of refractory focal epilepsy.

Active, not recruiting
Focal Epilepsy
Drug: BHV-7000
Drug: Placebo

This double-blind, Phase 2, multiple-dose study will be conducted to evaluate the PK/PD, efficacy, safety, and tolerability of apitegromab in subject...

Enrolling
Anti-myostatin
Neuromuscular Manifestations
Drug: Nusinersen
Drug: Risdiplam

The purpose of this study is to evaluate the long-term impact of treprostinil SMI on safety and efficacy by providing it to PH-COPD patients who part...

Begins enrollment in 3 months
Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease
Combination Product: treprostinil SMI (treprostinil inhalation spray)

A clinical trial of AAV5-hRKp.RPGR vector for participants with X-linked retinitis pigmentosa (XLRP)

Active, not recruiting
X-Linked Retinitis Pigmentosa
Biological: Genetic: AAV5-hRKp.RPGR Intermediate Dose
Biological: Genetic: AAV5-hRKp.RPGR Low Dose

The primary purpose of this study is to evaluate the safety and tolerability of treprostinil administered with a soft mist inhaler (SMI) over 16 week...

Not yet enrolling
Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease
Combination Product: Placebo (placebo inhalation spray)
Combination Product: treprostinil SMI (treprostinil inhalation spray)

Trial sponsors

Stanford University logo
United Therapeutics logo
M
Astellas logo
Biohaven logo
C
C
Genentech logo
I
Janssen (J&J Innovative Medicine) logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems